Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2010 6
2011 7
2012 4
2013 13
2014 11
2015 19
2016 31
2017 33
2018 42
2019 49
2020 44
2021 78
2022 73
2023 81
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

461 results

Results by year

Filters applied: . Clear all
The following terms were ignored: "", OR
Page 1
Diagnosis and Treatment of Bipolar Disorder: A Review.
Nierenberg AA, Agustini B, Köhler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M. Nierenberg AA, et al. JAMA. 2023 Oct 10;330(14):1370-1380. doi: 10.1001/jama.2023.18588. JAMA. 2023. PMID: 37815563 Review.
Antipsychotic agents, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine, are recommended, but some are associated with weight gain. ...First-line therapy includes mood stabilizers, such as lithium, anticonvulsants, such as valproate and lamotrigine, …
Antipsychotic agents, such as quetiapine, aripiprazole, asenapine, lurasidone, and cariprazine, are recommended, but some are associa …
Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.
Nuñez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, Veldic M, Seshadri A, Biernacka JM, Frye MA, Wang Z, Singh B. Nuñez NA, et al. J Affect Disord. 2022 Apr 1;302:385-400. doi: 10.1016/j.jad.2021.12.134. Epub 2022 Jan 2. J Affect Disord. 2022. PMID: 34986373 Free PMC article. Review.
Compared to placebo, ziprasidone, mirtazapine, and cariprazine had statistically significant higher discontinuation rates. ...Acceptability was lower with ziprasidone, mirtazapine, and cariprazine. Further research and head-to-head studies should be considered to st …
Compared to placebo, ziprasidone, mirtazapine, and cariprazine had statistically significant higher discontinuation rates. ...Accepta …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Yatham LN, et al. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. Bipolar Disord. 2018. PMID: 29536616 Free PMC article.
Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine alone or in combination are recommended as first-line treatments for acute mania. ...
Lithium, quetiapine, divalproex, asenapine, aripiprazole, paliperidone, risperidone, and cariprazine alone or in combination are reco …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
Yatham LN, Chakrabarty T, Bond DJ, Schaffer A, Beaulieu S, Parikh SV, McIntyre RS, Milev RV, Alda M, Vazquez G, Ravindran AV, Frey BN, Sharma V, Goldstein BI, Rej S, O'Donovan C, Tourjman V, Kozicky JM, Kauer-Sant'Anna M, Malhi G, Suppes T, Vieta E, Kapczinski F, Kanba S, Lam RW, Kennedy SH, Calabrese J, Berk M, Post R. Yatham LN, et al. Bipolar Disord. 2021 Dec;23(8):767-788. doi: 10.1111/bdi.13135. Epub 2021 Nov 1. Bipolar Disord. 2021. PMID: 34599629 Review.
For mania + mixed features second-line treatment options include asenapine, cariprazine, divalproex, and aripiprazole. In depression + mixed features, cariprazine and lurasidone are recommended as second-line options. ...
For mania + mixed features second-line treatment options include asenapine, cariprazine, divalproex, and aripiprazole. In depression …
New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression.
Orzelska-Górka J, Mikulska J, Wiszniewska A, Biała G. Orzelska-Górka J, et al. Int J Mol Sci. 2022 Sep 13;23(18):10624. doi: 10.3390/ijms231810624. Int J Mol Sci. 2022. PMID: 36142523 Free PMC article. Review.
The purpose of this review presents the background and evidence for the use of the new second/third-generation antipsychotics (aripiprazole, cariprazine, lurasidone, asenapine, brexpiprazole, lumateperone, pimavanserin) in treatment of schizophrenia and depression. ...
The purpose of this review presents the background and evidence for the use of the new second/third-generation antipsychotics (aripiprazole, …
Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?
Mohr P, Masopust J, Kopeček M. Mohr P, et al. Front Psychiatry. 2022 Jan 25;12:781946. doi: 10.3389/fpsyt.2021.781946. eCollection 2021. Front Psychiatry. 2022. PMID: 35145438 Free PMC article. Review.
There are no head-to-head comparisons between aripiprazole, brexpiprazole, or cariprazine. In two acute schizophrenia RCTs of cariprazine and brexpiprazole, aripiprazole was used as an indirect comparator to control for study sensitivity. ...In the therapy of bipola …
There are no head-to-head comparisons between aripiprazole, brexpiprazole, or cariprazine. In two acute schizophrenia RCTs of cari …
Cariprazine.
[No authors listed] [No authors listed] 2019 Feb 7. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2019 Feb 7. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999816 Free Books & Documents. Review.
No information is available on the use of cariprazine during breastfeeding. Until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant....
No information is available on the use of cariprazine during breastfeeding. Until more data become available, an alternate drug may b …
New Antipsychotic Medications in the Last Decade.
Pahwa M, Sleem A, Elsayed OH, Good ME, El-Mallakh RS. Pahwa M, et al. Curr Psychiatry Rep. 2021 Nov 29;23(12):87. doi: 10.1007/s11920-021-01298-w. Curr Psychiatry Rep. 2021. PMID: 34843030 Review.
RECENT FINDINGS: We identified 11 significant developments: the introduction of new antipsychotics cariprazine, brexpiprazole, lumateperone, and pimavanserin; introduction of new delivery methods: subcutaneous long-acting risperidone, aripiprazole lauroxil, transdermal ase …
RECENT FINDINGS: We identified 11 significant developments: the introduction of new antipsychotics cariprazine, brexpiprazole, lumate …
Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.
Vas C, Jain A, Trivedi M, Jha MK, Mathew SJ. Vas C, et al. Psychiatr Clin North Am. 2023 Jun;46(2):261-275. doi: 10.1016/j.psc.2023.02.012. Epub 2023 Mar 25. Psychiatr Clin North Am. 2023. PMID: 37149344 Review.
Atypical antipsychotics are the most widely studied augmentation agent and aripiprazole, brexpiprazole, cariprazine, quetiapine extended-release, and olanzapine-fluoxetine combination are approved for depression. ...
Atypical antipsychotics are the most widely studied augmentation agent and aripiprazole, brexpiprazole, cariprazine, quetiapine exten …
Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.
Yan Y, Yang X, Wang M, Chen B, Yin L, Ma X. Yan Y, et al. Psychol Med. 2022 Sep;52(12):2224-2231. doi: 10.1017/S0033291722001246. Epub 2022 Aug 22. Psychol Med. 2022. PMID: 35993319 Review.
Regarding efficacy, response rates indicated that all antipsychotics except for ziprasidone were more efficacious than the placebo, with the odds ratios (ORs) ranging from 1.34 for olanzapine and cariprazine [95% credible interval (CrI) 1.04-1.73 and 1.07-1.67, respectivel …
Regarding efficacy, response rates indicated that all antipsychotics except for ziprasidone were more efficacious than the placebo, with the …
461 results